PharmEasy acquires Aknamed in $180-$190 million stock deal, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The acquisition, which is similar to its purchase of Thyrocare in June, is part of the Mumbai-based company’s plans to position itself as a broader online healthcare firm, diversifying from being just an online medicine delivery platform., The acquisition, which is similar to its purchase of Thyrocare in June, is part of the Mumbai-based company’s plans to position itself as a broader online healthcare firm, diversifying from being just an online medicine delivery platform., , Read More